List of bibliographic references
Number of relevant bibliographic references: 21.
[0-20] [
0 - 20][
0 - 21][
20-20][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000217 (2020) |
A. Al-Sharqi [Malaisie] ; K. Apun [Malaisie] ; M. Vincent [Malaisie] ; D. Kanakaraju [Malaisie] ; L M Bilung ; M S H. Sum [Malaisie] | Investigation of the antibacterial activity of Ag-NPs conjugated with a specific antibody against Staphylococcus aureus after photoactivation. |
| 000272 (2019) |
Amritha Ramakrishnan [Pérou] ; Nina M. Schumack [États-Unis] ; Christina L. Gariepy [États-Unis] ; Heather Eggleston [États-Unis] ; Gladys Nunez [Pérou] ; Nereyda Espinoza [Pérou] ; Monica Nieto [Pérou] ; Rosa Castillo [Pérou] ; Jesus Rojas [Pérou] ; Andrea J. Mccoy [Pérou] ; Zoltan Beck [États-Unis] ; Gary R. Matyas [États-Unis] ; Carl R. Alving [États-Unis] ; Patricia Guerry [États-Unis] ; Frédéric Poly [États-Unis] ; Renee M. Laird [Israël, États-Unis] | Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21. |
| 000403 (2018) |
Moon H. Nahm [États-Unis] ; Jigui Yu [États-Unis] ; Hailey P. Weerts [États-Unis] ; Heather Wenzel [États-Unis] ; Chitradevi S. Tamilselvi [États-Unis] ; Lakshmi Chandrasekaran [États-Unis] ; Marcela F. Pasetti [États-Unis] ; Sachin Mani [États-Unis] ; Robert W. Kaminski [États-Unis] | Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay. |
| 000406 (2019) |
Ofir Schuster [États-Unis, Israël] ; Khandra T. Sears [États-Unis] ; Girish Ramachandran [États-Unis] ; Fabien J. Fuche [États-Unis] ; Brittany Curtis [États-Unis] ; Sharon M. Tennant [États-Unis] ; Raphael Simon [États-Unis] | Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein. |
| 000470 (2018) |
Gregory A. Price [États-Unis] ; Margaret C. Bash [États-Unis] | Development of an FHbp-CTB holotoxin-like chimera and the elicitation of bactericidal antibodies against serogroup B Neisseria meningitidis. |
| 000528 (2017) |
Kathryn A. Matthias [États-Unis] ; Michael Brad Strader [États-Unis] ; Hesham F. Nawar [États-Unis] ; Yamei S. Gao [États-Unis] ; Joonseong Lee [États-Unis] ; Dhilon S. Patel [États-Unis] ; Wonpil Im [États-Unis] ; Margaret C. Bash [États-Unis] | Heterogeneity in non-epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis. |
| 000629 (2016) |
Mark S. Riddle ; Robert W. Kaminski [États-Unis] ; Claudio Di Paolo [Suisse] ; Chad K. Porter [États-Unis] ; Ramiro L. Gutierrez [États-Unis] ; Kristen A. Clarkson [États-Unis] ; Hailey E. Weerts [États-Unis] ; Christopher Duplessis [États-Unis] ; Amy Castellano [États-Unis] ; Cristina Alaimo [Suisse] ; Kristopher Paolino [États-Unis] ; Robert Gormley [États-Unis] ; Veronica Gambillara Fonck | Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. |
| 000A04 (2012) |
Elizabeth E. Moran [États-Unis] ; Robert Burden ; Joseph E. Labrie ; Zhiyun Wen ; Xin-Min Wang ; Wendell D. Zollinger ; Lan Zhang ; Valerian B. Pinto | Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine. |
| 000A39 (2011) |
Valerian B. Pinto [États-Unis] ; Elizabeth E. Moran ; Francisco Cruz ; Xin-Ming Wang ; Arthur Fridman ; Wendell D. Zollinger ; Craig T. Przysiecki ; Robert Burden | An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups. |
| 000A44 (2011) |
Deborah H. Schmiel [États-Unis] ; Elizabeth E. Moran ; Paul B. Keiser ; Brenda L. Brandt ; Wendell D. Zollinger | Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B. |
| 000A71 (2011) |
P B Keiser [États-Unis] ; S. Biggs-Cicatelli ; E E Moran ; D H Schmiel ; V B Pinto ; R E Burden ; L B Miller ; J E Moon ; R A Bowden ; J F Cummings ; W D Zollinger | A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. |
| 000A86 (2010) |
Paul B. Keiser [États-Unis] ; Barnett T. Gibbs ; Trinka S. Coster ; E Ellen Moran ; Mark B. Stoddard ; Joseph E. Labrie ; Deborah H. Schmiel ; Valerian Pinto ; Ping Chen ; Wendell D. Zollinger | A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. |
| 000A98 (2010) |
Wendell D. Zollinger [États-Unis] ; Mikhail A. Donets ; Deborah H. Schmiel ; Valerian B. Pinto ; Joseph E. Labrie ; Elizabeth E. Moran ; Brenda L. Brandt ; Boris Ionin ; Ryan Marques ; Max Wu ; Ping Chen ; Mark B. Stoddard ; Paul B. Keiser | Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine. |
| 000B27 (2009) |
Wendell D. Zollinger [États-Unis] ; Elizabeth E. Moran ; Deborah H. Schmiel | Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity. |
| 000C26 (2005) |
Makda Fisseha [États-Unis] ; Ping Chen ; Brenda Brandt ; Todd Kijek ; Elizabeth Moran ; Wendell Zollinger | Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. |
| 000C89 (1994) |
E E Moran ; B L Brandt ; W D Zollinger | Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. |
| 000D19 (1988) |
N J Parsons [Royaume-Uni] ; P V Patel ; E L Tan ; J R Andrade ; C A Nairn ; M. Goldner ; J A Cole ; H. Smith | Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. |
| 000D24 (1987) |
A. Kimura ; C C Patrick ; E E Miller ; L D Cope ; G H Mccracken ; E J Hansen | Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. |
| 000D31 (1986) |
E. Wedege ; L O Fr Holm | Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. |
| 000D35 (1983) |
F J Silverblatt ; I. Ofek | Interaction of bacterial pili and leukocytes. |
| 000D41 (1981) |
M A Horwitz ; S C Silverstein | Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Antibodies, Bacterial"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i \
-Sk "Antibodies, Bacterial" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Terre
|area= SilverBacteriV1
|flux= Main
|étape= Curation
|type= indexItem
|index= MedMesh.i
|clé= Antibodies, Bacterial
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 1 22:59:42 2021. Site generation: Mon Feb 1 23:01:29 2021 |  |
